Abstract
We have shown deficits in monocyte phagocytosis from patients with age-related macular degeneration (AMD). Cell membrane fluidity is known to affect phagocytic capacity and leucocyte functionality more generally. Therefore, we examined membrane fluidity of peripheral blood leucocytes in human patients with AMD and in the P2X7 null mouse model of AMD using flow cytometry with a fluorescent probe for fluidity, TMA-DPH. The results showed that membrane fluidity was decreased in all leucocyte types of late AMD relative to healthy controls (HC) including monocytes, neutrophils and lymphocytes but this was not apparent in earlier stages of AMD. Further analysis of factors contributing to membrane fluidity indicated that pre-treatment of monocytes and lymphocytes with ATP greatly increased membrane fluidity in humans and mice. Evidence from P2X7 null mice and P2X7 antagonists confirmed that these ATP-driven increases in membrane fluidity were mediated by P2X7 but were not associated with the classic P2X7 functions of pore formation or phagocytosis. Analysis of P2X7 expression indicated that receptor levels were elevated in classic monocytes of late AMD patients, further suggesting the P2X7 may contribute to altered plasma membrane properties. Our findings identified a novel biological function of P2X7 in modulating membrane fluidity of leucocytes and demonstrated reduced membrane fluidity in cellular changes associated with the late stage of AMD.
Similar content being viewed by others
Data availability
All records, raw data and analysis are stored in compliance with the institutions’ requirements and are available upon approved request. This manuscript does not have supplemental information.
References
Fleckenstein M, Keenan TDL, Guymer RH et al (2021) Age-related macular degeneration. Nat Rev Dis Primers 7(1):31
Wu Z, Guymer RH (2020) Can the onset of atrophic age-related macular degeneration be an acceptable endpoint for preventative trials? Ophthalmologica 243(6):399–403
Gu BJ, Huang X, Avula PK et al (2021) Deficits in monocyte function in age related macular degeneration: a novel systemic change associated with the disease. Front Med 8:634177
Sluyter R, Shemon AN, Hughes WE et al (2007) Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes. Am J Physiol Regul Integr Comp Physiol 293(5):R2090-2098
Wong J, Gu BJ, Teoh H et al (2022) Flow cytometry identifies an early stage of platelet apoptosis produced by agonists of the P2X1 and P2X7 receptors. Platelets 33(4):1–11
Ferrari D, Chiozzi P, Falzoni S et al (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159(3):1451–1458
Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA (2000) ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 165(8):4615–4623
Gu BJ, Saunders BM, Petrou S, Wiley JS (2011) P2X7 is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP. J Immunol 187(5):2365–2375
Gu BJ, Saunders BM, Jursik C, Wiley JS (2010) The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of non-opsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood 115(8):1621–1631
Gu BJ, Baird PN, Vessey KA et al (2013) A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration. FASEB J 27(4):1479–1487
Vessey KA, Gu BJ, Jobling AI et al (2017) Loss of function of P2X7 receptor scavenger activity in aging mice: a novel model for investigating the early pathogenesis of age-related macular degeneration. Am J Pathol 187(8):1670–1685
Membrane fluidity. Verlag US: Springer, Boston, MA, 1984.
Tian B, Al-Moujahed A, Bouzika P et al (2017) Atorvastatin promotes phagocytosis and attenuates pro-inflammatory response in human retinal pigment epithelial cells. Sci Rep 7(1):2329
Schumann J (2016) It is all about fluidity: fatty acids and macrophage phagocytosis. Eur J Pharm 785:18–23
Ingraham LM, Boxer LA, Haak RA, Baehner RL (1981) Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes. Blood 58(4):830–835
Illinger D, Kubina M, Duportail G, Poindron P, Bartholeyns J, Kuhry JG (1989) TMA-DPH a fluorescent probe of membrane dynamics in living cells. How to use it in phagocytosis. Cell Biophys 14(1):17–26
Muller S, Masson V, Droesch S, Donner M, Stoltz JF (1989) Phagocytosis and membrane fluidity: application to the evaluation of opsonizing properties of fibronectin. Biorheol 26(2):323–330
Fernandez-Perez EJ, Sepulveda FJ, Peters C et al (2018) Effect of cholesterol on membrane fluidity and association of abeta oligomers and subsequent neuronal damage: a double-edged sword. Front Aging Neurosci 10:226
Yu Q, Cheng X (2021) Hydroxyurea-induced membrane fluidity decreasing as a characterization of neuronal membrane aging in Alzheimer’s disease. Aging 13(9):12817–12832
Boue-Grabot E, Akimenko MA, Seguela P (2000) Unique functional properties of a sensory neuronal P2X ATP-gated channel from zebrafish. J Neurochem 75(4):1600–1607
Ferris FL 3rd, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmol 120(4):844–851
Solle M, Labasi J, Perregaux DG et al (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276(1):125–132
Chazotte B (2011) Labeling the plasma membrane with TMA-DPH. Cold Spring Harbor protocols 2011(5): pdb prot5622
Jursik C, Sluyter R, Georgiou JG, Fuller SJ, Wiley JS, Gu BJ (2007) A quantitative method for routine measurement of cell surface P2X7 receptor function in leucocyte subsets by two-colour time-resolved flow cytometry. J Immunol Methods 325(1–2):67–77
Zhu D, Bungart BL, Yang X, Zhumadilov Z, Lee JC, and Askarova S (2015) Role of membrane biophysics in Alzheimer’s-related cell pathways. Front Neurosci 9(186
Cardoso C, Afonso C, and Bandarra NM (2016) Dietary DHA and health: cognitive function ageing. Nutr Res Rev: 1–14
el-Moatassim C and Dubyak GR (1993) Dissociation of the pore-forming and phospholipase D activities stimulated via P2z purinergic receptors in BAC1.2F5 macrophages. Product inhibition of phospholipase D enzyme activity. J Biol Chem 268(21): 15571-15578
Gargett CE, Cornish EJ, Wiley JS (1996) Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem J 313(Pt 2):529–535
Kahlenberg JM, Dubyak GR (2004) Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Cell Physiol 286(5):C1100-1108
Li W (2013) Phagocyte dysfunction, tissue aging and degeneration. Ageing Res Rev 12:1005–1012
Noble JM, Thomas TH, Ford GA (1999) Effect of age on plasma membrane asymmetry and membrane fluidity in human leukocytes and platelets. J Gerontol A Biol Sci Med Sci 54(12):M601-606
Fiorini R, Bertoli E, Kantar A, Giorgi PL, Curatola G (1989) Modifications of erythrocyte membrane fluidity of in vivo functionally aged human erythrocytes. Boll Soc Ital Biol Sper 65(8):703–710
Vavvas DG, Daniels AB, Kapsala ZG et al (2016) Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment. EBioMedicine 5:198–203
Guymer RH, Baird PN, Varsamidis M et al (2013) Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. PLoS ONE 8(12):e83759
Acknowledgements
We thank Mrs. Melinda Cain for her help in blood collection.
Funding
This work was supported by ARC Future Fellowship (BG, FT120100581) and NHMRC Project Grant (1048082, 1061419, 1120095), Principal Research Fellowship (RG, 1103013), Macular Disease Foundation Australia Project Grant (2014–2016), Macular Society Grant USA (2015), BrightFocus Foundation Project Grant (M2016061) and the Victorian Government’s Operational Infrastructure Support Grant to the Florey Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The study was approved by the Royal Victorian Eye and Ear Hospital human ethics committee (AMDRF95/283H/20) and by the Eastern Health human ethics committee (E05/1011). The animal work was approved by the Florey Institute Animal Ethics Committee (13–053-FNI).
Informed consent
The research adhered with the Declaration of Helsinki, and written informed consent was obtained from all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Robyn H. Guymer and Ben J. Gu are co-senior authors.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Drysdale, C., Park, K., Vessey, K.A. et al. P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration. Purinergic Signalling 18, 469–479 (2022). https://doi.org/10.1007/s11302-022-09894-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-022-09894-y